Rinostop Extra spray naz. 0.05% fl.
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Russia
Package quantity, pcs
one
Latin name
Rinostop
Release form
Nasal spray
Packaging
Bottle 15 ml.
pharmachologic effect
Rinostop is a vasoconstrictor for topical use in ENT practice.
Alpha adrenergic agonist.
When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease.
With rhinitis, it facilitates nasal breathing.
Pharmacokinetics
When applied topically, it is practically not absorbed, plasma concentrations are so small that they cannot be determined by modern analytical methods.
Indications
Acute allergic rhinitis, sinusitis, hay fever, otitis media (to reduce swelling of the nasopharyngeal mucosa), preparing the patient for diagnostic procedures in the nasal passages.
Contraindications
Angle-closure glaucoma, atrophic rhinitis, arterial hypertension, tachycardia, severe atherosclerosis, hyperthyroidism, surgery on the meninges (in history), hypersensitivity to xylometazoline.
Application during pregnancy and lactation
During pregnancy and lactation, it should be used only after a careful assessment of the risk-benefit ratio for the mother and the fetus, it is not allowed to exceed the recommended doses.
Structure
1 ml spray contains:
Active substance: xylometazoline.
Method of administration and dosage
Intranasally.
Spraying is performed after removing the safety cap from the sprayer.
The nebulizer is inserted into the nose and, by pressing on its base, spray for 1 second.
For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough
should not be applied more than 3 times a day.
For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day
should not be applied more than 3 times a day.
Do not use the drug without interruption for more than 3-5 days.
Side effects
With frequent and / or prolonged use: mucosal irritation, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.
Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, cardiac arrhythmias, increased blood pressure, headache, vomiting, sleep disorders, visual disturbances.
With long-term use in high doses: depressive state.
Storage conditions
In a dry, dark place at a temperature not exceeding 25 В° C.
Shelf life
3 years
Active substance
Xylometazoline
Name ENG
RHINOSTOP EXTRA
ATX code
oxymetazoline
Dosage
0.05% x 15ml
Structure
Composition per ml: Active ingredient: Oxymetazoline hydrochloride - 0.5 mg.
Excipients: Citric acid monohydrate - 0.609 mg
sodium citrate dihydrate - 3.823 mg
glycerol - 24.348 mg
benzalkonium chloride - 0.15 mg
purified water - up to 1 ml.
Indications
Difficulty in nasal breathing with colds, sinus inflammation, eustachitis, hay fever, allergic rhinitis, congestion and edema of the conjunctiva.
Contraindications
Inflammation of the nasal mucosa without secretion, chronic heart failure, hyperthyroidism, diabetes mellitus, pregnancy, children under 6 years of age (for eye drops), hypersensitivity to oxymetazoline, atrophic rhinitis, lactation period, arrhythmias, severe atherosclerosis, arterial hypertension, chronic renal failure , angle-closure glaucoma.
INN / Active ingredient
oxymetazoline hydrochloride
Storage conditions and periods
At a temperature not higher than 25 degrees.
Expiration date: 2 years
Specifications
Category
Runny nose
Scope of the medicinal product
Ear, Throat, Nose
Release form
Spray
Manufacturer country
Russia
Package quantity, pcs
one
Minimum age from
6 years
Way of introduction
Nasally
Vacation conditions
Without recipe
Volume, ml.
15 ml
Brand name
OTCPharm
The amount of the dosage form in the primary package
15 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Decongestant - alpha adrenergic agonist
Anatomical and therapeutic characteristics
R01AA05 Oxymetazoline
Dosage form
Nasal spray
The target audience
Children
Expiration date in days
730
Dosage (volume) of the substance in the preparation
0.5 mg
Package weight, g
2
Mode of application
:
Intranasal. < br> < br> Spraying is performed after removing the protective cap from the nebulizer. < br> < br> The nebulizer is inserted into the nose and, pressing on its base, spray for 1 second. < br> < br> For adults and children over the age of 6 years (0.1% spray): one injection from a nebulizer into each nasal passage, usually 3-4 injections per day are enough
should not be applied more than 3 times a day. < br> < br> For children aged 2 to 6 years (0.05% spray), one spray from a nebulizer into each nasal passage 1 or 2 times a day
should not be used more than 3 times a day. < br> Do not use the drug without interruption for more than 3-5 days.